Skip to main content
. 2020 Jul 27;21(15):5330. doi: 10.3390/ijms21155330
ALIAmides Autacoid local injury antagonist amides
BBB Blood–brain barrier
BSCB Blood-spinal cord barrier
CCI Chronic constriction injury
CIPN Chemotherapy-induced peripheral neuropathy
CNS Central nervous system
DPN Diabetic painful neuropathy (DPN)
GPR Receptor G-protein coupling
IASP International Association for the Study of Pain
MAPK Mitogen-activated protein kinase
MC Mast cell
m-PEA micronized-PEA
NAAA N-acylethanolamine-hydrolyzing acid amidase
NAEs N-acyl ethanolamines
OEA Oleoyl ethanolamide
PEA Palmitoyl ethanolamide
PEA-OXA 2-pentadecyl-2-oxazoline
PGA N-Palmitoyl-d-glucosamine
PNI Peripheral nerve injury
PNS Peripheral nervous system
PPAR-α Peroxisome proliferator-activated receptor-α
ROS Reactive oxygen species
SEA Stearoyl ethanolamide
SNI Spared nerve injury
SNRIs Serotonin-norepinephrine reuptake inhibitors
STZ Streptozotocin
TRPV1 Transient receptor potential vanilloid receptor type 1
TCAs Tricyclic antidepressants
um-PEA Ultramicronized-PEA